Knowthestock.com
BRKR - Bruker Corp

Sell

Moderate Growth but DecliningStock Price Very High
WeakStrong
WeakStrong

51%

based on last 5 year data.
Income Statement is MODERATE
Revenue Growth is -42.16%
Operating Income Growth is -41.93%
Net Income Growth is -80.18%
Earnings Per Share (EPS) Growth is -81.02%
Net Margin is 35.74%
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 1.57
Debt Ratio is 0.34
Current Debt to Net Income Ratio is 2.17
Total Debt to Total Assets Ratio is 0.36
Cash Flow is WEAK
Cash from Operations Growth is 3.55%
Capital Expenditure is High
Net Increase in Cash is Negative
Long Term Score Trend is NEGATIVE
Investment Risk is High
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Bruker Corp (BRKR) - https://www.bruker.com/
right from the beginning, which is now more than fifty years ago, bruker has been driven by a single idea: to provide the best technological solution for each analytical task. today, worldwide, more than 6,500 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. bruker continues to build upon its extensive range of products and solutions, expand its broad base of installed systems and maintain a strong reputation amongst its customers. as one of the world's leading analytical instrumentation companies, bruker remains focused on developing state-of-the-art technologies and innovative solutions for today’s ever complex analytical questions. bruker - innovation with integrity. bruker corporation company pages bruker axs: https://www
Exchange - NASDAQ
Industry - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector - Professional, Scientific, and Technical Services
CEO - Frank Laukien
Employees - 857
    Close

    Login/Register

    Home


Cookie Policy
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2025 and future.